In today’s Pharma Pulse, industry leaders warn of serialization security issues and pharma companies brace for the 2033 NDC ...
Regulatory regimes such as the EU FMD and U.S. DSCSA drive serialization to strengthen visibility and oversight, but these ...
Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, ...
Pharmaceutical & Cosmetics Anti-Counterfeit Packaging Market In-Depth Insights, Business Opportunities And Top Companies Analysis Forecast By 2030. The Pharma & Cosmetic Anti-Counterfeit Packaging ...
Authentication solutions emerge as pharma industry’s strongest shield against counterfeits at TAF Connect 2026: Shardul Nautiyal, Mumbai Friday, March 20, 2026, 08:00 Hrs [IST] ...
BOCA RATON, Fla.-- (BUSINESS WIRE)--March 19, 2026-- ...
DSCSA is in maintenance mode, but the National Drug Code promises to disrupt the industry with the move from 10-12 digits.
U.S. prescription drugs market project to grow from $634 billion market to $883 billion by 2030 according to Grandview Research[1] Global blockchain in healthcare market is projected to grow from $11 ...
Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain ™ U.S. prescription drugs market project to grow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results